The Indian pharmaceutical giant, Wockhardt, is facing financial distress and this presents an unmissable opportunity for major players in the global pharmaceutical market. A recent decline in stock value has signaled potential vulnerability, making it a prime target for companies looking to increase their footprint. With a rich history and experti